{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:16:16Z","timestamp":1782890176394,"version":"3.54.5"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Few clinical and preclinical articles reported the potential usefulness of <jats:sup>18<\/jats:sup>F-choline PET\/CT in several hematological proliferative diseases. We report and incidental finding of a superscan-like pattern in a patient affected by essential thrombocythemia (ET), performing <jats:sup>18<\/jats:sup>F-choline PET\/CT for a biochemical recurrence of prostate cancer. The mild elevation of PSA values and the negativity of subsequent <jats:sup>68<\/jats:sup>Ga-PSMA-11 PET\/CT allowed to correlate the diffuse skeletal uptake detected on <jats:sup>18<\/jats:sup>F-choline PET\/CT to the underlying hematologic disease, rather than to a prostate cancer relapse.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004474","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T21:25:20Z","timestamp":1675286720000},"page":"e131-e132","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Superscan-Like Pattern on 18F-Choline PET\/CT in a Patient With Essential Thrombocythemia"],"prefix":"10.1097","volume":"48","author":[{"given":"Luca","family":"Urso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Nieri","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit, Oncological Medical and Specialists Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Borgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Malorgio","sequence":"additional","affiliation":[{"name":"U.O.C. Radiotherapy, University Hospital of Ferrara, Ferrara, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirco","family":"Bartolomei","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit, Oncological Medical and Specialists Department"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.1097\/RLU.0000000000003695","article-title":"Bone marrow activation after chemotherapy presenting as diffuse skeletal uptake on 18F-fluorocholine PET\/CT","volume":"46","year":"2021","journal-title":"Clin Nucl med"},{"key":"bib2-20250621","first-page":"19","article-title":"The future of choline PET in the era of prostate specific membrane antigen","volume":"63","year":"2019","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s00259-017-3670-z","article-title":"68Ga-PSMA PET\/CT: Joint EANM and SNMMI Procedure Guideline for Prostate Cancer Imaging: Version 1.0","volume":"44","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s11547-018-0929-9","article-title":"68Ga-PSMA-PET: added value and future applications in comparison to the current use of choline-PET and mpMRI in the workup of prostate cancer","volume":"123","year":"2018","journal-title":"Radiol Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s00256-019-03230-z","article-title":"Comparison of PSMA-PET\/CT, choline-PET\/CT, NaF-PET\/CT, MRI, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a systematic review and meta-analysis","volume":"48","year":"2019","journal-title":"Skeletal Radiol"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3390\/pharmaceutics13060911","article-title":"ChoK-full of potential: choline kinase in B cell and T cell malignancies","volume":"13","year":"2021","journal-title":"Pharmaceutics"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1097\/RLU.0000000000001080","article-title":"Skeletal superscan on 18F-choline PET\/CT cases of myeloproliferative disease","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3390\/cancers12061394","article-title":"Choline PET\/CT in multiple myeloma","volume":"12","year":"2020","journal-title":"Cancers (Basel)"},{"key":"bib9-20250621","first-page":"622501","article-title":"PET\/CT in multiple myeloma: beyond FDG","volume":"10","year":"2020","journal-title":"Front Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004474","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:03:03Z","timestamp":1750536183000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004474","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,22]]}}}